BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32976788)

  • 1. Rectal Spacer Usage with Proton Radiation Therapy for Prostate Cancer.
    Thompson AB; Hamstra DA
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):644-648. PubMed ID: 32976788
    [No Abstract]   [Full Text] [Related]  

  • 2. Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103.
    Taggar AS; Charas T; Cohen GN; Boonyawan K; Kollmeier M; McBride S; Mathur N; Damato AL; Zelefsky MJ
    Brachytherapy; 2018; 17(2):251-258. PubMed ID: 29241706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study--The IPI Trial.
    Habl G; Uhl M; Katayama S; Kessel KA; Hatiboglu G; Hadaschik B; Edler L; Tichy D; Ellerbrock M; Haberer T; Wolf MB; Schlemmer HP; Debus J; Herfarth K
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):435-443. PubMed ID: 27084659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
    Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can We Advance Proton Therapy for Prostate? Considering Alternative Beam Angles and Relative Biological Effectiveness Variations When Comparing Against Intensity Modulated Radiation Therapy.
    Underwood T; Giantsoudi D; Moteabbed M; Zietman A; Efstathiou J; Paganetti H; Lu HM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):454-464. PubMed ID: 27084660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal toxicity after proton therapy for prostate cancer: an analysis of outcomes of prospective studies conducted at the university of Florida Proton Therapy Institute.
    Colaco RJ; Hoppe BS; Flampouri S; McKibben BT; Henderson RH; Bryant C; Nichols RC; Mendenhall WM; Li Z; Su Z; Morris CG; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):172-81. PubMed ID: 25442338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rectum-spacer related acute toxicity - endoscopy results of 403 prostate cancer patients after implantation of gel or balloon spacers.
    Schörghofer A; Drerup M; Kunit T; Lusuardi L; Holzinger J; Karner J; Groher M; Zoubek C; Forstner R; Sedlmayer F; Wolf F
    Radiat Oncol; 2019 Mar; 14(1):47. PubMed ID: 30876433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-modality applicability of rectal normal tissue complication probability models from photon- to proton-based radiotherapy.
    Pedersen J; Flampouri S; Bryant C; Liang X; Mendenhall N; Li Z; Liu M; Muren LP
    Radiother Oncol; 2020 Jan; 142():253-260. PubMed ID: 31630864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyethylene glycol hydrogel rectal spacer implantation in patients with prostate cancer undergoing combination high-dose-rate brachytherapy and external beam radiotherapy.
    Yeh J; Lehrich B; Tran C; Mesa A; Baghdassarian R; Yoshida J; Torrey R; Gazzaniga M; Weinberg A; Chalfin S; Ravera J; Tokita K
    Brachytherapy; 2016; 15(3):283-287. PubMed ID: 26853354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI findings of absorbable hydrogel spacer for prostate cancer therapy: a pictorial review.
    Rohr A; Werth K; Shen X; Collins Z; Fishback S; Jones J; Ash R; Williams V
    Abdom Radiol (NY); 2019 Jan; 44(1):247-251. PubMed ID: 29967983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution analysis of hydrogel spacer and evaluation of rectal dose reduction in Japanese prostate cancer patients undergoing stereotactic body radiation therapy.
    Kobayashi H; Eriguchi T; Tanaka T; Ogata T; Ishida M; Nakajima Y; Kumabe A; Kosugi M
    Int J Clin Oncol; 2021 Apr; 26(4):736-743. PubMed ID: 33415570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published Data.
    Karsh LI; Gross ET; Pieczonka CM; Aliotta PJ; Skomra CJ; Ponsky LE; Nieh PT; Han M; Hamstra DA; Shore ND
    Urology; 2018 May; 115():39-44. PubMed ID: 29174940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protons for prostate cancer: the dream versus the reality.
    Lawrence TS; Feng M
    J Natl Cancer Inst; 2013 Jan; 105(1):7-8. PubMed ID: 23243201
    [No Abstract]   [Full Text] [Related]  

  • 15. Decision analysis model evaluating the cost of a temporary hydrogel rectal spacer before prostate radiation therapy to reduce the incidence of rectal complications.
    Hutchinson RC; Sundaram V; Folkert M; Lotan Y
    Urol Oncol; 2016 Jul; 34(7):291.e19-26. PubMed ID: 27038698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectal spacing, prostate coverage, and periprocedural outcomes after hydrogel spacer injection during low-dose-rate brachytherapy implantation.
    Kahn J; Dahman B; McLaughlin C; Kapoor P; Kapoor R; Harris E; Sharma M; Schutzer M; Moghanaki D
    Brachytherapy; 2020; 19(2):228-233. PubMed ID: 32085930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogel rectum-prostate spacers mitigate the uncertainties in proton relative biological effectiveness associated with anterior-oblique beams.
    Underwood TS; Voog JC; Moteabbed M; Tang S; Soffen E; Cahlon O; Lu HM; Zietman AL; Efstathiou JA; Paganetti H
    Acta Oncol; 2017 Apr; 56(4):575-581. PubMed ID: 28075206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a hydrogel spacer in three-dimensional conformal radiation therapy for prostate cancer.
    Ogita M; Yamashita H; Sawayanagi S; Takahashi W; Nakagawa K
    Jpn J Clin Oncol; 2020 Mar; 50(3):303-309. PubMed ID: 31926489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
    Rana S; Cheng C; Zhao L; Park S; Larson G; Vargas C; Dunn M; Zheng Y
    J Med Radiat Sci; 2017 Mar; 64(1):18-24. PubMed ID: 27741379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application technique: placement of a prostate-rectum spacer in men undergoing prostate radiation therapy.
    Hatiboglu G; Pinkawa M; Vallée JP; Hadaschik B; Hohenfellner M
    BJU Int; 2012 Dec; 110(11 Pt B):E647-52. PubMed ID: 22788857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.